Skip to main content

Market Overview

Ovid Therapeutics Inc. (OVID)

3.58 +0.28 (8.48%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/20/21Cantor FitzgeraldDowngradesNeutral4.0
12/02/20CitigroupDowngradesNeutral4.0
12/02/20JMP SecuritiesDowngradesMarket Perform
8/26/20CitigroupMaintainsBuy10.0
6/18/20Cantor FitzgeraldMaintainsOverweight13.0
9/24/19CitigroupMaintainsBuy10.0
9/24/19CitiMaintainsBuy10.0
9/04/19RBC CapitalInitiates Coverage OnOutperform12.0
11/15/18Cantor FitzgeraldInitiates Coverage OnOverweight
4/20/18Ladenburg ThalmannInitiates Coverage OnBuy27.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter